ARTICLE | Top Story
EC approves Amgen's cinacalcet
October 28, 2004 7:00 AM UTC
The EC granted marketing approval to AMGN for its Mimpara cinacalcet to treat secondary hyperparathyroidism in chronic kidney disease patients on dialysis and to treat elevated calcium levels in patie...